iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement

PixoTech® licensing shifted in as iXensor’s new growth engine to meet self-testing strong demand in the post-pandemic era Taipei, Taiwan / Osaka, Japan, April 27th, 2022 – iXensor Co., Ltd. (6734. TWO) iXensor, the pioneer of mobile health, today announced that Rohto Pharmaceutical Co., Ltd, a multinational pharmaceutical corporation headquartered in Japan, has…

read more